Vanderbilt Ingram Cancer Center

Adding an investigational drug to an already approved estrogen blocking therapy appears to be safe and provided clinical benefit for some postmenopausal women with estrogen-positive breast cancer. Read More

The Vanderbilt-Ingram Cancer Center (VICC) at Franklin has added new technology to enhance treatment for patients needing radiation therapy or stereotactic body radiation. Read More

Vanderbilt’s Department of Otolaryngology-Head and Neck Surgery and Vanderbilt-Ingram Cancer Center are providing free head and neck cancer screenings Friday, April 17. The screenings are open to the public and no appointments are needed. Read More

Of every 100 people in the United States, at least three men or women will be diagnosed with head and neck cancer in their lifetimes. These cancers can occur in the nasal cavity, sinuses, throat, lips, mouth, thyroid, salivary glands or the voice box (larynx). Read More

Vanderbilt-Ingram Cancer Center investigators have identified the mechanisms used by a gene and its binding protein to drive tumor growth in several forms of cancer, including non-small cell lung cancer. Read More

Douglas Johnson, M.D. Douglas Johnson, M.D., assistant professor of Medicine, has been named a recipient of the National Comprehensive Cancer Network (NCCN) Foundation Young Investigator Awards. The two-year grant will provide $150,000 in funding for his research on survivorship among cancer patients who receive drugs… Read More

Vanderbilt-Ingram Cancer Center, along with Nashville Public Television (NPT), the American Cancer Society and Gilda’s Club Nashville, will sponsor a special community event to preview an upcoming PBS television documentary on cancer. Read More

Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators. Read More

Two Vanderbilt-Ingram Cancer Center (VICC) leaders have been named to a panel of the Institute of Medicine (IOM) to help shape national policies on the use of biomarkers for targeted cancer therapies. Read More

Improvements in cancer diagnosis and treatment have led to longer survival for most cancer patients in the United States. However, the improvement in survival was substantially greater among younger patients and those who are white in most of the cancers studied, according to new research by Vanderbilt University investigators. Read More

Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been named a fellow of the AACR Academy. Read More

Country music group BlackHawk recently presented a check for $20,000 to Harold (Hal) Moses, M.D., Ingram Professor of Cancer Research and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), in support of cancer research. Read More

A specific gene expression profile represents a novel, biologically relevant “signature” for identifying colon cancers with high risk of metastatic recurrence, Vanderbilt researchers have found. Read More

Vanderbilt is embarking on an observational study to define and understand how a promising treatment for multiple myeloma affects the heart. Read More

Vanderbilt-Ingram Cancer Center (VICC) patient William Ostman smiled while gazing into a camera lens and declared, “I am a prostate cancer survivor.” Read More

Two leading cancer organizations are calling for regulation of e-cigarettes and other electronic nicotine delivery systems (ENDS). Read More

Melanoma is the most lethal form of skin cancer, with high mortality rates. While new drugs have been approved to treat the disease, patients nearly always develop resistance to the therapies and the cancer advances. Read More

A protein that degrades the “matrix” between cells participates in the development of lung metastases from primary breast cancer in mouse models and may be a good target for breast cancer treatment. Read More

The Vanderbilt Cardio-Oncology program has fostered a collaborative relationship combining the expertise of cardiologists and oncologists to understand effects of cancer therapy on the heart. Read More

Every holiday season, members of the Vanderbilt Community Chorus sing holiday-themed carols to Vanderbilt-Ingram Cancer Center patients, family members and visitors. Read More